Lymphatic vessel density and expressions of lymphangiogenic growth factors in salivary carcinomas

Neoplasma

Volumn 58, Issue 4, 2011, Pages 331-336

  Mello, M F ^a   Costa, A F ^a   Freitas, L L ^a   Soares, A B ^b   Araujo, V C ^b   Tincani, A J ^a   Martins, A S ^a   Altemani, A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

Author keywords

HGF; Lymph vessels; Salivary carcinoma; VEGF C

Indexed keywords

GROWTH FACTOR; MONOCLONAL ANTIBODY D2-40; SCATTER FACTOR; VASCULOTROPIN C; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CELL INTERACTION; CHILD; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HISTOLOGY; HUMAN; LYMPH VESSEL; LYMPHANGIOGENESIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; SCHOOL CHILD; TUMOR CELL; BIOSYNTHESIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; SALIVARY GLAND TUMOR; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHILD; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; RISK FACTORS; SALIVARY GLAND NEOPLASMS; TISSUE ARRAY ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; YOUNG ADULT;

EID: 80052553982     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_04_331     Document Type: Article

References (32)

1. RÉGIS DE BRITO SANTOS I, KOWALSKI LP, ARAUJO VC, LOGULLO AF, MAGRIN J. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinomas. Arch Otolaryngol Head Neck Surg 2001; 127: 56-60.
2. KELLEY DJ, SPIRO RH. Management of the neck in parotid carcinoma. Am J Surg 1996; 172: 695-7. doi:10.1016/S0002-9610(96)00307-8
3. FERLITO A, SHAHA AR, RINALDO A, MONDIN V. Management of clinically negative cervical lymph nodes in patients with malignant neoplasms of the parotid gland. ORL J Otorhinolaryngol Relat Spec 2001; 63: 123-6. doi:10.1159/000055726
4. STENNERT E, KISNER D, JUNGEHUELSING M, Guntinas-Lichius O, SCHRÖDER U et al. High incidence of lymph node metastasis in major salivary gland cancer Arch Otolaryngol Head Neck Surg 2003; 129: 720-3. doi:10.1001/archotol.129.7.720
5. LLOYD S, YU JB, WILSON LD, DECKER RH. A prognostic index for predicting lymph node metastasis in minor salivary gland cancer. Int J Radiat Oncol Biol Phys 2010; 76: 169-75. doi:10.1016/j.ijrobp.2009.01.021
6. BEASLEY NJ, PREVO R, BANERJI S, LEEK RD. MOORE J et al. Intratumoral lymphangiogenesis and lymph node metasta- sis in head and neck cancer. Cancer Res 2002; 62: 1315-20.
7. FRANCHI A, GALLO O, MASSI D, BARONI G, SANTUCCI M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma. A morphometric study with clinical correlations. Cancer 2004; 101: 973-8. doi:10.1002/cncr.20454
8. KYZAS PA, GELEFF S, BATISTATOU A, AGNANTIS NJ, STEFANOU D. Evidence for lymphangiogenesis and its prog- nostic implications in head and neck squamous cell carcinoma. J Pathol 2005; 206: 170-7. doi:10.1002/path.1776
9. AUDET N, BEASLEY NJ, MACMILLAN C, JACKSON DG, GULLANE PJ, et al. Lymphatic vessel density, nodal metas- tases, and prognosis in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2005; 131: 1065-70. doi:10.1001/archotol.131.12.1065
10. SOARES AB, PONCHIO L, JULIANO PB, ARAÚJO VC, ALTEMANI A. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma. J Clin Pathol 2007; 60: 995-00. doi:10.1136/jcp.2006.042523
11. SOARES AB, ARAÚJO VC, JULIANO PB, ALTEMANI A. An-giogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma. J Oral Pathol Med. 2009; 38: 623-9.
12. TEYMOORTASH A, SCHRADER C, SHIMODA H, KATO S, WERNER JA. Evidence of lymphangiogenesis in Warthin's tumor of the parotid gland. Oral Oncol. 2007; 43: 614-8. doi:10.1016/j.oraloncology.2006.07.006
13. CAO Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005; 5: 735-43. doi:10.1038/nrc1693
14. CAO R, BJÖRNDAHL MA, GALLEGO MI, CHEN S, RELIGA P, HANSEN AJ, CAO Y. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 2006; 107: 3531-6. doi:10.1182/blood-2005-06-2538
15. MIYAHARA M, TANUMA J, SUGIHARA K, SEMBA I. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carci- noma. Cancer 2007; 110: 1287-94. doi:10.1002/cncr.22900
16. WILLIAMS CS, LEEK RD, ROBSON AM, BANERJI S, PREVO R et al. Absence of lymphangiogenesis and intratu- moural lymph vessels in human metastatic breast cancer. J Pathol 2003; 200: 195-06. doi:10.1002/path.1343
17. SCHOPPMANN SF, HORVAT R, BIRNER P. Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphang- iogenic therapies (Review). Oncol Rep 2002; 9: 455-60.
18. SCHMID K, BIRNER P, GRAVENHORST V, END A, GELEFF S. Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung. Am J Surg Pathol 2005; 29: 324-8 doi:10.1097/01.pas.0000149706.74216.b6
19. KOUKOURAKIS MI, GIATROMANOLAKI A, SIVRIDES E, SIMOPOULOS C, GATTER KC et al. LYVE-1 immunohis-tochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 2005; 58: 202-6. doi:10.1136/ jcp.2004.019174
20. DADRAS SS, PAUL T, BERTONCINI J, BROWN LF, MUZIKANSKY A, JACKSON DG et al. Tumor lymphangio- genesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 2003; 162: 1951-60. doi:10.1016/S0002-9440(10)64328-3
21. [21] GOMBOS Z, XU X, CHU CS, ZHANG PJ, ACS G. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix. Clin Cancer Res 2005; 11:,8364-71. doi:10.1158/1078-0432.CCR-05-1238
22. PADERA TP, KADAMBI A, DI TOMASO E, CARREIRA CM, BROWN EB et al. Lymphatic metastasis in the absence of functional intratumoral lymphatics. Science 2002; 296: 1883-6. doi:10.1126/science.1071420
23. XUAN M, FANG YR, WATO M, HATA S, TANAKA A. Immunohistochemical co-localization of lymphatics and blood vessels in oral squamous cell carcinomas. J Oral Pathol Med 2005; 34: 334-9. doi:10.1111/j.1600-0714.2005.00316.x
24. KARPANEN T, EGEBLAD M, KARKKAINEN MJ, KUBO H, Ylä-Herttuala S et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001; 61:1786-90.
25. MANDRIOTA SJ, JUSSILA L, JELTSH M, COMPAGNI A, BAETENS D et al. Vascular endothelial growth factor-C- mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001; 20: 672-82. doi:10.1093/emboj/20.4.672
26. SKOBE M, HAWIGHORST T, JACKSON DG, PREVO R, JANES L et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7: 192-8. doi:10.1038/84643
27. STACKER SA, CAESAR C, BALDWIN ME, THORNTON GE, WILLIAMS RA et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001; 7: 186-91. doi:10.1038/84635
28. OHNO F, NAKANISHI H, ABE A, KINISHITA A, HASEGAWA Y et al. Regional difference in intratumoral lymphangiogenesis of oral squamous cell carcinomas evalu- ated by immunohistochemistry using D2-40 and podoplanin antibody: an analysis in comparison with angiogenesis. J Oral Pathol Med 2007; 36: 281-9. doi:10.1111/j.1600-0714.2007.00529.x
29. SCHOPPMANN SF, BIRNER P, STÖCKL J, KALT R, ULLRICH R et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peri- tumoral lymphangiogenesis. Am J Pathol 2002; 161: 947-56. doi:10.1016/S0002-9440(10)64255-1
30. VAN DER AUWERA I, CAO Y, TILLE JC, PEPPER MS, JACKSON DG et al. First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours. Br J Cancer 2006; 95: 1611-25. doi:10.1038/sj.bjc.6603445
31. ALI MA. Lymphatic microvessel density and the expression of lymphangiogenic factors in oral squamous cell carcinoma. Med Princ Pract 2008; 17: 486-92. doi:10.1159/000151572
32. TSUKINOKI K, YASUDA M, MORI Y, ASANO S, NAITO H et al. Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma. Oncol Rep 2004; 12: 1017-21.